The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin
International Journal of Molecular Sciences · 14.02.2025 · 26 (4) · 1618
DOI: 10.3390/ijms26041618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2025. Verfasst von Hannah R Dawe und 1 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute of Dermatology, King's College London, London SE1 9RT, UK. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Skin. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Psoriasis Foundation, Psoriasis Association.
Abstract (Originalsprache)
In the last decade, the aryl hydrocarbon receptor (AHR) has emerged as a critical peacekeeper for the maintenance of healthy skin. The evolutionary conservation of AHR implied physiological functions for this receptor, beyond the detoxification of man-made compounds, a notion further supported by the existence of physiological AHR ligands, notably derivates of tryptophan by the host and host microbiome. The UV light-derived ligand, 6-formylindolo[3,2-b]carbazole (FICZ), anticipated a role for AHR in skin, a UV light-exposed organ, where physiological AHR activation promotes a healthy skin barrier and constrains inflammation. The clinical development of tapinarof, the first topical AHR modulating drug for inflammatory skin disease, approved by the FDA for mild-to-moderate psoriasis and poised for approval in atopic dermatitis, supports the therapeutic targeting of the AHR pathway to harness its beneficial effect in skin inflammation. Here, we describe how a tightly controlled, physiological activation of the AHR pathway maintains skin homeostasis, and discuss how the pathway is dysregulated in psoriasis and atopic dermatitis, identifying areas offering opportunities for alternative therapeutic approaches, for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St John's Institute of Dermatology, King's College London, London SE1 9RT, UK.
- KHP Centre for Translational Medicine, London SE1 9RT, UK.
ORCID-Profile: Paola Di Meglio
Förderung
- Medical Research Council
- National Psoriasis Foundation
- Psoriasis Association
- UK Medical Research Council
- King’s Health Partners Centre for Translational Medicine
Zitieren
APA
Dawe, H. R., & Di Meglio, P. (2025). The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin. International Journal of Molecular Sciences, 26(4), 1618. https://doi.org/10.3390/ijms26041618
Vancouver
Dawe HR, Di Meglio P. The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin. International Journal of Molecular Sciences. 2025;26(4):1618. doi:10.3390/ijms26041618
BibTeX
@article{Dawe2025,
author = {Dawe, Hannah R and Di Meglio, Paola},
title = {The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1618},
doi = {10.3390/ijms26041618}
}
EUVIMED